Cancer · 2015 · 63 citations · 24 references
MedicineOncologyPathologyBreast OncologyCancer EpidemiologyNeoplasiaBreast Cancer Risk AssessmentBreast DisordersBreast PathologyMammary TumorsAtypical Ductal HyperplasiaAtypical Lobular HyperplasiaBenign Breast NeoplasmsBenign Breast TumorsBreast Cancer Risk StratificationBreast HyperplasiaBreast Risk AssessmentCancer Risk Assessment
BACKGROUND: Women with atypical hyperplasia (AH) on a benign breast biopsy specimen are at increased risk for the development of breast cancer. However, the relation between the type and extent of AH (atypical ductal hyperplasia [ADH] vs atypical lobular hyperplasia [ALH]) and the magnitude of the breast cancer risk is not well defined. METHODS: A nested case-control study of benign breast disease and breast cancer risk was conducted. Women with breast cancer and prior benign breast biopsy findings (488 cases) were matched to women with prior benign breast biopsy findings who were free from breast cancer (1907 controls). Benign breast biopsy slides were reviewed and categorized as nonproliferative, proliferative without atypia, or AH (ADH or ALH). The number of foci of AH was also recorded. RESULTS: Among women with ADH, the interrelation between the extent of atypia and breast cancer risk was not significant (odds ratio [OR] for 1 or 2 foci, 3.5; 95% confidence interval [CI], 2.2-5.6; OR for ≥3 foci, 2.7; 95% CI, 1.4-5.1; P = .41). Similarly, although the risk with ALH was higher for those with ≥3 foci than for those with <3 foci, the difference was not statistically significant (OR for 1 or 2 foci, 5.2; 95% CI, 2.7-10.0; OR for ≥3 foci, 8.0; 95% CI, 4.5-14.2; P = .19). CONCLUSIONS: This analysis demonstrates that the extent of ADH or ALH does not significantly contribute to breast cancer risk. The lack of a significant dose-response relation between the extent and type of atypia and breast cancer risk suggests that it would be premature to use the extent of atypia to influence management decisions for women with ADH or ALH.
24
Atypical hyperplastic lesions of the female breast. A long-term follow-up study
David L. Page, William D. Dupont, Lowell W. Rogers et al. · Cancer · 1985 · 968 citations
Benign Breast Disease and the Risk of Breast Cancer
Lynn C. Hartmann, Thomas A. Sellers, Marlene H. Frost et al. · New England Journal of Medicine · 2005 · 942 citations · Full text
TEST OF THE NATIONAL DEATH INDEX
Meir J. Stampfer, Walter C. Willett, Frank E. Speizer et al. · American Journal of Epidemiology · 1984 · 792 citations